Intraday Economic News: U.S. Personal Income Rises 0.4% in October; Spending Up 0.1% Nov 11

  • ID: 2027881
  • November 2011
  • Region: United States
  • Standard & Poors
1 of 2

U.S. personal income was up 0.4% month over month in October--slightly stronger than the 0.3% consensus expectation and the 0.1% pace seen in September. Consumer spending rose only 0.1% from the prior month. This was much weaker than the 0.4% consensus expectation and was surprising, given the stronger-than-expected October retail sales and the healthy International Council of Shopping Centers chain-store sales figures reported last week. This came after September spending was revised up to a 0.7% pace (was 0.6%). Disposable income rose 0.3% from a 0.1% pace in September. The savings rate rose to 3.5% in October from 3.3% the month before. The personal consumption expenditures price index fell 0.1% month over month, decelerating from the 0.2% pace in September....

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Commentary
Criteria articles describe the thought process and methodology Standard & Poor's analysts use in determining ratings. These commentary pieces discuss both the quantitative (economic and financial) and qualitative (business analysis and caliber of management) aspects of the analysis, as well as legal issues.

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.